nodes	percent_of_prediction	percent_of_DWPC	metapath
Lercanidipine—CACNA1C—Nicotine Activity on Chromaffin Cells—CHRNB4—nicotine dependence	0.0878	0.305	CbGpPWpGaD
Lercanidipine—CACNA1C—Nicotine Activity on Chromaffin Cells—CHRNA3—nicotine dependence	0.0665	0.231	CbGpPWpGaD
Lercanidipine—Hoarseness—Varenicline—nicotine dependence	0.0301	0.0423	CcSEcCtD
Lercanidipine—Aphthous stomatitis—Varenicline—nicotine dependence	0.0282	0.0396	CcSEcCtD
Lercanidipine—Myositis—Varenicline—nicotine dependence	0.027	0.0379	CcSEcCtD
Lercanidipine—Pharyngolaryngeal pain—Varenicline—nicotine dependence	0.0196	0.0275	CcSEcCtD
Lercanidipine—Laryngeal pain—Varenicline—nicotine dependence	0.0194	0.0273	CcSEcCtD
Lercanidipine—Rhinorrhoea—Varenicline—nicotine dependence	0.0163	0.0229	CcSEcCtD
Lercanidipine—Dysphonia—Varenicline—nicotine dependence	0.0161	0.0226	CcSEcCtD
Lercanidipine—CYP3A7—Xenobiotics—CYP2A7—nicotine dependence	0.0155	0.0538	CbGpPWpGaD
Lercanidipine—Nocturia—Varenicline—nicotine dependence	0.0143	0.02	CcSEcCtD
Lercanidipine—Leukocytosis—Varenicline—nicotine dependence	0.0141	0.0198	CcSEcCtD
Lercanidipine—Hyperkalaemia—Varenicline—nicotine dependence	0.013	0.0183	CcSEcCtD
Lercanidipine—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0128	0.0446	CbGpPWpGaD
Lercanidipine—Urine output increased—Varenicline—nicotine dependence	0.012	0.0168	CcSEcCtD
Lercanidipine—Lymphadenopathy—Varenicline—nicotine dependence	0.0113	0.0158	CcSEcCtD
Lercanidipine—CYP3A5—Xenobiotics—CYP2A7—nicotine dependence	0.0112	0.0389	CbGpPWpGaD
Lercanidipine—Sleep disorder—Varenicline—nicotine dependence	0.0111	0.0156	CcSEcCtD
Lercanidipine—Diabetes mellitus—Varenicline—nicotine dependence	0.0111	0.0155	CcSEcCtD
Lercanidipine—Polyuria—Varenicline—nicotine dependence	0.0109	0.0154	CcSEcCtD
Lercanidipine—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.01	0.0348	CbGpPWpGaD
Lercanidipine—Arthritis—Varenicline—nicotine dependence	0.00989	0.0139	CcSEcCtD
Lercanidipine—Hypoglycaemia—Varenicline—nicotine dependence	0.00985	0.0138	CcSEcCtD
Lercanidipine—Cerebrovascular accident—Varenicline—nicotine dependence	0.00981	0.0138	CcSEcCtD
Lercanidipine—Migraine—Varenicline—nicotine dependence	0.00946	0.0133	CcSEcCtD
Lercanidipine—Abdominal pain upper—Varenicline—nicotine dependence	0.00878	0.0123	CcSEcCtD
Lercanidipine—Breast disorder—Varenicline—nicotine dependence	0.00869	0.0122	CcSEcCtD
Lercanidipine—Cramp muscle—Varenicline—nicotine dependence	0.00866	0.0122	CcSEcCtD
Lercanidipine—Nasopharyngitis—Varenicline—nicotine dependence	0.0086	0.0121	CcSEcCtD
Lercanidipine—Asthma—Varenicline—nicotine dependence	0.00831	0.0117	CcSEcCtD
Lercanidipine—Angina pectoris—Varenicline—nicotine dependence	0.00809	0.0114	CcSEcCtD
Lercanidipine—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.00795	0.0276	CbGpPWpGaD
Lercanidipine—Pollakiuria—Varenicline—nicotine dependence	0.00767	0.0108	CcSEcCtD
Lercanidipine—Erectile dysfunction—Varenicline—nicotine dependence	0.00765	0.0107	CcSEcCtD
Lercanidipine—Photosensitivity reaction—Varenicline—nicotine dependence	0.00758	0.0106	CcSEcCtD
Lercanidipine—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.00734	0.0103	CcSEcCtD
Lercanidipine—Acute coronary syndrome—Varenicline—nicotine dependence	0.0073	0.0103	CcSEcCtD
Lercanidipine—Myocardial infarction—Varenicline—nicotine dependence	0.00726	0.0102	CcSEcCtD
Lercanidipine—Stomatitis—Varenicline—nicotine dependence	0.00722	0.0101	CcSEcCtD
Lercanidipine—Hepatobiliary disease—Varenicline—nicotine dependence	0.00701	0.00984	CcSEcCtD
Lercanidipine—Urinary tract disorder—Varenicline—nicotine dependence	0.00657	0.00922	CcSEcCtD
Lercanidipine—Oedema peripheral—Varenicline—nicotine dependence	0.00655	0.0092	CcSEcCtD
Lercanidipine—Connective tissue disorder—Varenicline—nicotine dependence	0.00653	0.00917	CcSEcCtD
Lercanidipine—Urethral disorder—Varenicline—nicotine dependence	0.00652	0.00915	CcSEcCtD
Lercanidipine—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00643	0.0223	CbGpPWpGaD
Lercanidipine—CYP3A7—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00634	0.022	CbGpPWpGaD
Lercanidipine—Erythema multiforme—Varenicline—nicotine dependence	0.00629	0.00883	CcSEcCtD
Lercanidipine—Eye disorder—Varenicline—nicotine dependence	0.00621	0.00873	CcSEcCtD
Lercanidipine—Tinnitus—Varenicline—nicotine dependence	0.0062	0.00871	CcSEcCtD
Lercanidipine—Cardiac disorder—Varenicline—nicotine dependence	0.00617	0.00867	CcSEcCtD
Lercanidipine—Angiopathy—Varenicline—nicotine dependence	0.00603	0.00847	CcSEcCtD
Lercanidipine—Immune system disorder—Varenicline—nicotine dependence	0.00601	0.00843	CcSEcCtD
Lercanidipine—Mediastinal disorder—Varenicline—nicotine dependence	0.00599	0.00841	CcSEcCtD
Lercanidipine—Mental disorder—Varenicline—nicotine dependence	0.00583	0.00818	CcSEcCtD
Lercanidipine—Erythema—Varenicline—nicotine dependence	0.00579	0.00813	CcSEcCtD
Lercanidipine—Malnutrition—Varenicline—nicotine dependence	0.00579	0.00813	CcSEcCtD
Lercanidipine—Dysgeusia—Varenicline—nicotine dependence	0.00567	0.00796	CcSEcCtD
Lercanidipine—Muscle spasms—Varenicline—nicotine dependence	0.00557	0.00781	CcSEcCtD
Lercanidipine—Vision blurred—Varenicline—nicotine dependence	0.00546	0.00766	CcSEcCtD
Lercanidipine—Ill-defined disorder—Varenicline—nicotine dependence	0.00537	0.00754	CcSEcCtD
Lercanidipine—Anaemia—Varenicline—nicotine dependence	0.00535	0.00751	CcSEcCtD
Lercanidipine—Angioedema—Varenicline—nicotine dependence	0.00529	0.00743	CcSEcCtD
Lercanidipine—Malaise—Varenicline—nicotine dependence	0.00522	0.00733	CcSEcCtD
Lercanidipine—CYP3A7—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00521	0.0181	CbGpPWpGaD
Lercanidipine—Vertigo—Varenicline—nicotine dependence	0.0052	0.0073	CcSEcCtD
Lercanidipine—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.0052	0.0181	CbGpPWpGaD
Lercanidipine—Syncope—Varenicline—nicotine dependence	0.00519	0.00729	CcSEcCtD
Lercanidipine—Palpitations—Varenicline—nicotine dependence	0.00512	0.00718	CcSEcCtD
Lercanidipine—Loss of consciousness—Varenicline—nicotine dependence	0.00509	0.00714	CcSEcCtD
Lercanidipine—Cough—Varenicline—nicotine dependence	0.00505	0.00709	CcSEcCtD
Lercanidipine—Arthralgia—Varenicline—nicotine dependence	0.00493	0.00692	CcSEcCtD
Lercanidipine—Myalgia—Varenicline—nicotine dependence	0.00493	0.00692	CcSEcCtD
Lercanidipine—Chest pain—Varenicline—nicotine dependence	0.00493	0.00692	CcSEcCtD
Lercanidipine—Anxiety—Varenicline—nicotine dependence	0.00491	0.0069	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00489	0.00687	CcSEcCtD
Lercanidipine—Discomfort—Varenicline—nicotine dependence	0.00487	0.00684	CcSEcCtD
Lercanidipine—Dry mouth—Varenicline—nicotine dependence	0.00482	0.00677	CcSEcCtD
Lercanidipine—Shock—Varenicline—nicotine dependence	0.00465	0.00653	CcSEcCtD
Lercanidipine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00464	0.0161	CbGpPWpGaD
Lercanidipine—Nervous system disorder—Varenicline—nicotine dependence	0.00463	0.00651	CcSEcCtD
Lercanidipine—Thrombocytopenia—Varenicline—nicotine dependence	0.00463	0.00649	CcSEcCtD
Lercanidipine—Tachycardia—Varenicline—nicotine dependence	0.00461	0.00647	CcSEcCtD
Lercanidipine—Skin disorder—Varenicline—nicotine dependence	0.00459	0.00644	CcSEcCtD
Lercanidipine—CYP3A5—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00458	0.0159	CbGpPWpGaD
Lercanidipine—Hyperhidrosis—Varenicline—nicotine dependence	0.00457	0.00641	CcSEcCtD
Lercanidipine—Anorexia—Varenicline—nicotine dependence	0.0045	0.00632	CcSEcCtD
Lercanidipine—Hypotension—Varenicline—nicotine dependence	0.00441	0.0062	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.0043	0.00604	CcSEcCtD
Lercanidipine—Insomnia—Varenicline—nicotine dependence	0.00427	0.006	CcSEcCtD
Lercanidipine—Dyspnoea—Varenicline—nicotine dependence	0.00421	0.00591	CcSEcCtD
Lercanidipine—Somnolence—Varenicline—nicotine dependence	0.0042	0.0059	CcSEcCtD
Lercanidipine—Dyspepsia—Varenicline—nicotine dependence	0.00416	0.00584	CcSEcCtD
Lercanidipine—Decreased appetite—Varenicline—nicotine dependence	0.00411	0.00577	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00408	0.00573	CcSEcCtD
Lercanidipine—Fatigue—Varenicline—nicotine dependence	0.00407	0.00572	CcSEcCtD
Lercanidipine—Constipation—Varenicline—nicotine dependence	0.00404	0.00567	CcSEcCtD
Lercanidipine—Feeling abnormal—Varenicline—nicotine dependence	0.00389	0.00547	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Varenicline—nicotine dependence	0.00386	0.00542	CcSEcCtD
Lercanidipine—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00377	0.0131	CbGpPWpGaD
Lercanidipine—Urticaria—Varenicline—nicotine dependence	0.00375	0.00527	CcSEcCtD
Lercanidipine—Abdominal pain—Varenicline—nicotine dependence	0.00373	0.00524	CcSEcCtD
Lercanidipine—Body temperature increased—Varenicline—nicotine dependence	0.00373	0.00524	CcSEcCtD
Lercanidipine—Hypersensitivity—Varenicline—nicotine dependence	0.00348	0.00489	CcSEcCtD
Lercanidipine—Asthenia—Varenicline—nicotine dependence	0.00339	0.00476	CcSEcCtD
Lercanidipine—Pruritus—Varenicline—nicotine dependence	0.00334	0.00469	CcSEcCtD
Lercanidipine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0033	0.0115	CbGpPWpGaD
Lercanidipine—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00326	0.0113	CbGpPWpGaD
Lercanidipine—Diarrhoea—Varenicline—nicotine dependence	0.00323	0.00454	CcSEcCtD
Lercanidipine—Dizziness—Varenicline—nicotine dependence	0.00312	0.00439	CcSEcCtD
Lercanidipine—Vomiting—Varenicline—nicotine dependence	0.003	0.00422	CcSEcCtD
Lercanidipine—Rash—Varenicline—nicotine dependence	0.00298	0.00418	CcSEcCtD
Lercanidipine—Dermatitis—Varenicline—nicotine dependence	0.00298	0.00418	CcSEcCtD
Lercanidipine—Headache—Varenicline—nicotine dependence	0.00296	0.00416	CcSEcCtD
Lercanidipine—CYP3A7—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00294	0.0102	CbGpPWpGaD
Lercanidipine—Nausea—Varenicline—nicotine dependence	0.00281	0.00394	CcSEcCtD
Lercanidipine—CYP3A7—Biological oxidations—CYP2A7—nicotine dependence	0.00277	0.00961	CbGpPWpGaD
Lercanidipine—CYP3A7—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00273	0.00948	CbGpPWpGaD
Lercanidipine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00268	0.0093	CbGpPWpGaD
Lercanidipine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00216	0.0075	CbGpPWpGaD
Lercanidipine—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00213	0.0074	CbGpPWpGaD
Lercanidipine—CYP3A5—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00212	0.00737	CbGpPWpGaD
Lercanidipine—CYP3A5—Biological oxidations—CYP2A7—nicotine dependence	0.002	0.00695	CbGpPWpGaD
Lercanidipine—CYP3A5—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00197	0.00685	CbGpPWpGaD
Lercanidipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00175	0.00608	CbGpPWpGaD
Lercanidipine—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00151	0.00524	CbGpPWpGaD
Lercanidipine—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.00142	0.00494	CbGpPWpGaD
Lercanidipine—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.0014	0.00487	CbGpPWpGaD
Lercanidipine—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000986	0.00343	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.00093	0.00323	CbGpPWpGaD
Lercanidipine—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000917	0.00319	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—CYP2A7—nicotine dependence	0.000879	0.00306	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—CYP2A7—nicotine dependence	0.000773	0.00268	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—CYP2A7—nicotine dependence	0.000473	0.00164	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CYP2A7—nicotine dependence	0.000342	0.00119	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CYP2A7—nicotine dependence	0.000243	0.000845	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CYP2A7—nicotine dependence	0.000159	0.000553	CbGpPWpGaD
